Company intelligence / Profile preview

Dr Brad Stanfield

Auckland, New Zealand

Ownership: Private
Employees: ~5
Development stage: Other

Overview

Dr Brad Stanfield is a New Zealand-based physician and longevity researcher who operates a health technology and supplement company focused on extending human healthspan. The organization is notable for crowdfunding and conducting independent clinical trials, such as a study investigating the effects of rapamycin on muscle strength in older adults. In addition to research, the company provides evidence-based medical education through digital platforms and offers a line of high-quality dietary supplements. The business model integrates clinical research, digital health education, and direct-to-consumer wellness products.

Therapeutic areas: OtherMetabolic Disorders
Modalities: Small moleculeDietary supplement
Industry: Biotech

Beyond the preview

Go deeper on Dr Brad Stanfield.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dr Brad Stanfield.

Explore the full profile